Literature DB >> 20010343

Evaluating the age distribution of patients with colorectal cancer: are the United States Preventative Services Task Force guidelines for colorectal cancer screening appropriate?

Jason K Shellnut1, Harry J Wasvary, Marc B Grodsky, Judith A Boura, Stephen G Priest.   

Abstract

PURPOSE: Evaluate the appropriateness of the 2008 United States Preventative Services Task Force screening recommendations for colorectal cancer.
METHODS: Ages at diagnosis data were collected on patients with colorectal cancer from the William Beaumont Tumor Registry. The database identified 6,925 patients treated for colorectal cancer between January 1973 and December 2007. Patients were divided into 3 age groups at diagnosis categories (younger than 50 years old, those 50 to 75 years old, and those older than 75 years old) to evaluate whether there were changes in the age distribution, pathologic stage, or tumor location during the 35-year period.
RESULTS: The percent of patients with colorectal cancer older than age 75 years increased from 29% to 40% (P < .0001). The combined percentage of patients younger than age 50 years and older than age 75 years has increased from 36% (1973-1978) to 49% (2003-2007). The combined percentages of stage III and IV disease in patients younger than 50 years and older than 75 years were 51% and 34%, respectively (P < .0001). Rectal or left-sided lesions occurred in 68%, 64%, and 50% of patients younger than 50 years old, those 50 to 75 years old, and those older than 75 years old, respectively (P < .0001). Right-sided lesions occurred in 22%, 25%, and 37% of those younger than 50 years old, those 50 to 75 years old, and those older than 75 years old, respectively (P < .0001).
CONCLUSIONS: There has been a significant increase in the percentage of colorectal cancer patients older than age 75 years. Failing to screen patients younger than 50 years and older than the age of 75 years would miss 49% of patients treated at our institution from 2003 to 2007.

Entities:  

Mesh:

Year:  2010        PMID: 20010343     DOI: 10.1007/DCR.0b013e3181bc01d1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

1.  Colorectal cancer is reliably excluded in the frail and elderly population by minimal preparation CT.

Authors:  J H Saunders; D Miskovic; C Bowman; P Panto; A Menon
Journal:  Tech Coloproctol       Date:  2013-07-02       Impact factor: 3.781

2.  Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.

Authors:  Frank van Hees; J Dik F Habbema; Reinier G Meester; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber
Journal:  Ann Intern Med       Date:  2014-06-03       Impact factor: 25.391

3.  Evaluation of the appropriate age range of colorectal cancer screening based on the changing epidemiology in the past 20 years in taiwan.

Authors:  Huan-Cheng Chang; Jorng-Tzong Horng; Wen-Chu Lin; Hsin-Wen Lai; Cheng-Wei Chang; Tzu-An Chen
Journal:  ISRN Gastroenterol       Date:  2012-08-30

4.  Inequalities in cancer distribution in tehran; a disaggregated estimation of 2007 incidencea by 22 districts.

Authors:  Marzieh Rohani Rasaf; Rashid Ramezani; Mitra Mehrazma; Mohamad Reza Rohani Rasaf; Mohsen Asadi-Lari
Journal:  Int J Prev Med       Date:  2012-07

5.  Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study.

Authors:  Sameer D Saini; Sandeep Vijan; Philip Schoenfeld; Adam A Powell; Stephanie Moser; Eve A Kerr
Journal:  BMJ       Date:  2014-02-26

6.  Exploration of the Optimal Minimum Lymph Node Count after Colon Cancer Resection for Patients Aged 80 Years and Older.

Authors:  Xu Guan; Wei Chen; Zheng Jiang; Zheng Liu; Dazhuang Miao; Hanqing Hu; Zhixun Zhao; Runkun Yang; Xishan Wang
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

7.  Effect of Aspirin on Cancer Incidence and Mortality in Older Adults.

Authors:  John J McNeil; Peter Gibbs; Suzanne G Orchard; Jessica E Lockery; Wendy B Bernstein; Yin Cao; Leslie Ford; Andrew Haydon; Brenda Kirpach; Finlay Macrae; Catriona McLean; Jeremy Millar; Anne M Murray; Mark R Nelson; Galina Polekhina; Christopher M Reid; Ellen Richmond; Luz Maria Rodríguez; Raj C Shah; Jeanne Tie; Asad Umar; G J van Londen; Kathlyn Ronaldson; Rory Wolfe; Robyn L Woods; John Zalcberg; Andrew T Chan
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.